Article Details

Innovent Announced Financial Results for Full Year Ended December 31, 2020 and Corporate ...

Retrieved on: 2021-03-30 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Innovent Announced Financial Results for Full Year Ended December 31, 2020 and Corporate .... View article details on hiswai:

Excerpt

The 23 assets cover major areas including monoclonal antibodies, ... (IO) and the unique strength in monoclonal antibody and bispecific antibody, the ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo